Policies & Procedures

The MUSC IBC, under its Charter and Procedures and the NIH Guidelines, oversees all research at MUSC using recombinant DNA [rDNA], microbes [of all risk groups, RG 1-4], and certain biotoxins. Work with all Select Agents is included. The IBC will ensure that the proposed research is in compliance with all relevant portions of applicable federal, state and local laws, rules, regulations, and guidelines, including, but not limited to:

• MUSC Policies and Procedures for the Institutional Biosafety Committee (PDF)
• Institution-wide MUSC Biological Safety Policy (PDF)
• NIH Guidelines (current version) – NIH

• Biosafety in Microbiological and Biomedical Laboratories (BMBL) – CDC and NIH (current version)
• United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern
• Select Agent Regulations (7 C.F.R. Part 331, 9 C.F.R. Part 121, and 42 C.F.R. Part 73)
• HHS regulations for the Protection of Human Subjects (45 C.F.R. Part 46).
• FDA regulations (21 C.F.R.)
• USDA APHIS - Animal and Plant Health Inspection Service regulations
• DHEC - S.C. Department of Health & Environmental Control regulations
• All relevant policies and procedures of MUSC, including, but not limited to:
  • MUSC Human Research Protection Program Overview (PDF)
  • Infection Control Standard Precautions
  • Bloodborne Pathogens Protocols (PDF)
  • Red Bag Usage in the Disposal of Biohazardous/Regulated Waste